But with the exception of
AIDS, the pharmaceutical
industry hasn't taken much interest in developing
vaccines for common diseases, because they don't expect to make a profit.
The row over the Thai trials has been fuelled by an explosive mix of factors, including the pace at which the HIV epidemic is growing in Asia, the future of the
vaccines industry, and domestic tensions in the US between
AIDS researchers, activists and politicians.